A groundbreaking victory has been reached in the fight against malaria. Novartis announced today that its revolutionary treatment has received regulatory approval to address malaria in newborns and infants, signaling a major leap forward in global health. This innovative pharmaceutical will now be available for countries where malaria is most prev